Metraipolis › archive › dc_3d25eef09cd8
Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives — Europe PMC PMID:42666775
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42666775
- DOI
- 10.3389/fimmu.2026.1912199
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T14:08:15.863Z
- SHA-256 of the archived text
4133c0f50220d2aea36e14ce46dccdfe2d09bfc476211622ef3883b0f3fcf8c1- Stable URL of this page
https://metraipolis.com/documento/dc_3d25eef09cd8
How to cite
Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives — Europe PMC PMID:42666775 — Europe PMC (en), https://europepmc.org/article/MED/42666775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d25eef09cd8 (Metraipolis archive dc_3d25eef09cd8, sha256 4133c0f50220d2aea36e14ce46dccdfe2d09bfc476211622ef3883b0f3fcf8c1)
BibTeX
@misc{dc3d25eef09cd8,
title = {Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives — Europe PMC PMID:42666775},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42666775},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d25eef09cd8; sha256 4133c0f50220d2aea36e14ce46dccdfe2d09bfc476211622ef3883b0f3fcf8c1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666775. Agents can read the archived copy with the MCP tool read_document.